265 related articles for article (PubMed ID: 29542329)
1. Treating relapsed follicular lymphoma.
Erblich T; Montoto S
Expert Rev Hematol; 2018 May; 11(5):403-410. PubMed ID: 29542329
[TBL] [Abstract][Full Text] [Related]
2. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
3. Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies.
Milunović V; Bogeljić Patekar M; Jakubac KM; Mandac Rogulj I; Radić-Krišto D; Planinc-Peraica A; Ostojić Kolonić S
Acta Clin Croat; 2017 Mar; 56(1):143-156. PubMed ID: 29120553
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment strategies for follicular lymphoma].
Hiddemann W; Hoster E; Schmidt C; Dreyling M; Unterhalt M
Internist (Berl); 2016 Mar; 57(3):222-9. PubMed ID: 26842683
[TBL] [Abstract][Full Text] [Related]
5. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
Jacobson CA; Freedman AS
Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
[TBL] [Abstract][Full Text] [Related]
6. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.
Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH
J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078
[TBL] [Abstract][Full Text] [Related]
7. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
Kritharis A; Sharma J; Evens AM
Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
9. Treatment of follicular lymphoma: current status.
Tilly H; Zelenetz A
Leuk Lymphoma; 2008; 49 Suppl 1():7-17. PubMed ID: 18821428
[TBL] [Abstract][Full Text] [Related]
10. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma.
Matarasso S; Assouline S
Future Oncol; 2023 Oct; 19(31):2083-2101. PubMed ID: 37882361
[TBL] [Abstract][Full Text] [Related]
11. Rituximab maintenance versus retreatment in follicular lymphoma.
Palla AR; Hamadani M
Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
[TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
Cohen Y; Solal-Céligny P; Polliack A
Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
[TBL] [Abstract][Full Text] [Related]
13. Rituximab: a benchmark in the development of chemotherapy-free treatment strategies for follicular lymphomas.
Karmali R; Kimby E; Ghielmini M; Flinn IW; Gordon LI; Zucca E
Ann Oncol; 2018 Feb; 29(2):332-340. PubMed ID: 29206891
[TBL] [Abstract][Full Text] [Related]
14. Advances in Treatment of Follicular Lymphoma.
Luminari S; Trotman J; Federico M
Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456
[TBL] [Abstract][Full Text] [Related]
15. New developments in the treatment of follicular lymphoma.
Leonard JP
Rinsho Ketsueki; 2019; 60(9):1199-1204. PubMed ID: 31597844
[TBL] [Abstract][Full Text] [Related]
16. Current and future therapeutic approaches for the treatment of follicular lymphoma.
Pulsoni A; Cappelli LV; Ballotta L; Canichella M; Serrao A; Annechini G; D'Elia GM; Foà R
Expert Rev Anticancer Ther; 2018 Sep; 18(9):931-941. PubMed ID: 29972084
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma: time for a re-think?
Gandhi MK; Marcus RE
Blood Rev; 2005 May; 19(3):165-78. PubMed ID: 15748964
[TBL] [Abstract][Full Text] [Related]
18. Obinutuzumab in follicular lymphoma.
Martinez-Calle N; Figueroa-Mora R; Villar-Fernandez S; Marcos-Jubilar M; Panizo C
Drugs Today (Barc); 2016 Dec; 52(12):643-651. PubMed ID: 28276536
[TBL] [Abstract][Full Text] [Related]
19. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
20. The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
Norman JE; Schouten HC; Dreger P; Robinson SP
Bone Marrow Transplant; 2019 Jun; 54(6):787-797. PubMed ID: 30390063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
